218 related articles for article (PubMed ID: 30275053)
1. Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
Lopes-Ramos CM; Kuijjer ML; Ogino S; Fuchs CS; DeMeo DL; Glass K; Quackenbush J
Cancer Res; 2018 Oct; 78(19):5538-5547. PubMed ID: 30275053
[TBL] [Abstract][Full Text] [Related]
2. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract][Full Text] [Related]
3. A stroma-related lncRNA panel for predicting recurrence and adjuvant chemotherapy benefit in patients with early-stage colon cancer.
Zhou R; Sun H; Zheng S; Zhang J; Zeng D; Wu J; Huang Z; Rong X; Bin J; Liao Y; Shi M; Liao W
J Cell Mol Med; 2020 Mar; 24(5):3229-3241. PubMed ID: 31989761
[TBL] [Abstract][Full Text] [Related]
4. Research for Expression and Prognostic Value of GABRD in Colon Cancer and Coexpressed Gene Network Construction Based on Data Mining.
Liu T; Fang Y
Comput Math Methods Med; 2021; 2021():5544182. PubMed ID: 34194536
[TBL] [Abstract][Full Text] [Related]
5. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Hu D; Zhang B; Yu M; Shi W; Zhang L
Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
7. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
[TBL] [Abstract][Full Text] [Related]
8. Network-based identification of biomarkers for colon adenocarcinoma.
Hu F; Wang Q; Yang Z; Zhang Z; Liu X
BMC Cancer; 2020 Jul; 20(1):668. PubMed ID: 32680494
[TBL] [Abstract][Full Text] [Related]
9. Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme.
Lopes-Ramos CM; Belova T; Brunner TH; Ben Guebila M; Osorio D; Quackenbush J; Kuijjer ML
Cancer Res; 2021 Nov; 81(21):5401-5412. PubMed ID: 34493595
[TBL] [Abstract][Full Text] [Related]
10. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed genes regulated by methylation in colon cancer based on bioinformatics analysis.
Liang Y; Zhang C; Dai DQ
World J Gastroenterol; 2019 Jul; 25(26):3392-3407. PubMed ID: 31341364
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
[TBL] [Abstract][Full Text] [Related]
13. A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
Pentheroudakis G; Kotoula V; Fountzilas E; Kouvatseas G; Basdanis G; Xanthakis I; Makatsoris T; Charalambous E; Papamichael D; Samantas E; Papakostas P; Bafaloukos D; Razis E; Christodoulou C; Varthalitis I; Pavlidis N; Fountzilas G
BMC Cancer; 2014 Feb; 14():111. PubMed ID: 24555920
[TBL] [Abstract][Full Text] [Related]
14. Large differences in global transcriptional regulatory programs of normal and tumor colon cells.
Cordero D; Solé X; Crous-Bou M; Sanz-Pamplona R; Paré-Brunet L; Guinó E; Olivares D; Berenguer A; Santos C; Salazar R; Biondo S; Moreno V
BMC Cancer; 2014 Sep; 14():708. PubMed ID: 25253512
[TBL] [Abstract][Full Text] [Related]
15. KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).
Yoon HH; Tougeron D; Shi Q; Alberts SR; Mahoney MR; Nelson GD; Nair SG; Thibodeau SN; Goldberg RM; Sargent DJ; Sinicrope FA;
Clin Cancer Res; 2014 Jun; 20(11):3033-43. PubMed ID: 24687927
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
17. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
Wang XJ; Zeng B; Lin S; Chen M; Chi P
Ann Clin Lab Sci; 2019 Nov; 49(6):730-739. PubMed ID: 31882423
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Gao Z; Fu P; Yu Z; Zhen F; Gu Y
Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
[TBL] [Abstract][Full Text] [Related]
19. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
[TBL] [Abstract][Full Text] [Related]
20. Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.
Donada M; Bonin S; Nardon E; De Pellegrin A; Decorti G; Stanta G
J Cancer Res Clin Oncol; 2011 Feb; 137(2):201-10. PubMed ID: 20387074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]